/
/
/

Brooks Laboratories Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)69.15
Volume (₹)1.30 L
High (₹)73.40
Upper Circuit82.46
Low (₹)69.15
Lower Circuit54.98
Prev Close68.72
52W High (₹)129.44
Price72.71
52W Low (₹)36.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)202.52 Cr
Div. Yield (%)0.00
PE Ratio15.33
Debt to Equity0.06
Price to Book0.90
Book Value41.64
EPS (TTM)4.49
Face Value10.00
ROE (%)22.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
BROOKSNSE
LTP
1W Low
1W High
Market cap (₹)
1762.2+2.2 (0.13%)
1725.50
1776.60
4,19,620Cr
9099-241 (-2.58%)
8937.50
9431.50
2,39,714Cr
4630.2-26.7 (-0.57%)
4551.80
4682
1,74,741Cr
1128.7+11.2 (1.00%)
1107.30
1150.90
1,12,119Cr
2034.9-1.7 (-0.08%)
2007.80
2069.20
1,10,008Cr
1329.7+28.7 (2.21%)
1300.20
1333.30
1,06,061Cr
1229.6+32.6 (2.72%)
1196.90
1250.70
1,01,339Cr
2353.6-14.9 (-0.63%)
2317.50
2426.80
96,244Cr
1681.4-11.6 (-0.69%)
1647.10
1715
95,590Cr
1981.4+24.9 (1.27%)
1925.70
1984.80
89,391Cr
72.71+2.58 (3.68%)
63.30
73.45
203Cr

Key Highlights of Brooks Laboratories Ltd Balance Sheet

Brooks Laboratories Ltd balance sheet discloses shareholders' funds of ₹29.46Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹29.46Cr, and the reserves and surplus of the company is ₹91.39Cr.

The company has its non-current liabilities with total liabilities of ₹146.36Cr as of 2026-03-31.

The current liabilities are ₹21.81Cr as of 2026-03-31. At the same time, current assets are ₹37.42Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹90.53Cr and tangible assets of ₹14.52Cr, provided in the Brooks Laboratories Ltd financial statements.